Reveal Biosciences is a computational pathology company combining traditional histopathology with artificial intelligence to transform tissue biology into actionable data. Our technology pipeline includes a high-plex multiplex platform and machine learning computational pathology solutions to enable research, diagnostics, and clinical labs to analyze tissue samples more accurately and efficiently.

Reveal provides advanced tissue technologies including immunohistochemistry (IHC), in situ hybridization (ISH), histology, digital pathology and image analysis services to a broad range of pharmaceutical, biotech, academic and government institutions.Reveal Biosciences Acquired by CellCarta